Display options
Share it on

Cells. 2021 Dec 07;10(12). doi: 10.3390/cells10123440.

Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese .

Cells

Elena Makarova, Antonina Kazantseva, Anastasia Dubinina, Elena Denisova, Tatiana Jakovleva, Natalia Balybina, Nataliya Bgatova, Konstantin Baranov, Nadezhda Bazhan

Affiliations

  1. The Laboratory of Physiological Genetics, The Institute of Cytology and Genetics, 630090 Novosibirsk, Russia.
  2. The Institute of Molecular and Cellular Biology, 630090 Novosibirsk, Russia.

PMID: 34943946 DOI: 10.3390/cells10123440

Abstract

FGF21 is a promising candidate for treating obesity, diabetes, and NAFLD; however, some of its pharmacological effects are sex-specific in mice with the

Keywords: Ay mice; FGF21; gene expression; liver steatosis; obesity; sex differences

Publication Types

Grant support